Rapid Eukaryotic Impedimetric Biosensing of Naproxen and Isoniazid: A Proof-of-Concept for Acute Toxicity Monitoring
Biosensors · 20.05.2026 · 16 (5) · 298
DOI: 10.3390/bios16050298 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors, online erschienen am 20.05.2026. Verfasst von Zala Štukovnik und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chemistry and Chemical Engineering, University of Maribor, Smetanova Ulica 17, 2000 Maribor, Slovenia. Hauptthemen laut MEDLINE: Naproxen, Biosensing Techniques, Isoniazid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Slovenian Research and Innovation Agency, Slovenian Research and Innovation Agency, Republic of Slovenia.
Abstract (Originalsprache)
This study presents a rapid, eukaryotic impedimetric biosensor that applies the yeast Saccharomyces cerevisiae as a robust, cost-effective biorecognition element for monitoring the acute toxicity of two representative pharmaceuticals, naproxen and isoniazid, in aquatic systems. The biosensor utilizes a previously developed three-electrode system made from type 316 stainless steel. Yeast cells seeded onto these electrodes serve as the biosensing element. By monitoring changes in electrical impedance, the system quantifies the cellular stress induced by pharmaceutical exposure. Electrochemical Impedance Spectroscopy (EIS) revealed a concentration-dependent decrease in both resistance and capacitance, attributed to cell death and subsequent desorption from the working electrode surface. These findings were validated through optical density at 600 nm (OD600) growth curve analysis and methylene blue viability staining, which confirmed metabolic inhibition and membrane damage. Results indicate a linear response for naproxen within the 2.5 mM to 20 mM range, with a LOD of 0.509 mM, and for isoniazid within the 10 mM to 100 mM range, with a LOD of 0.684 mM. Naproxen demonstrated a more pronounced cytotoxic effect, with cell viability dropping to 41.08% at 10 mM compared to 68.79% for isoniazid. While conventional analytical methods focus on chemical quantification, this proof-of-concept biosensor provides a rapid toxic/non-toxic signal, offering a biologically relevant tool for real-time monitoring of industrial waste streams and acute environmental contamination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Chemistry and Chemical Engineering, University of Maribor, Smetanova Ulica 17, 2000 Maribor, Slovenia.
- Faculty of Mathematics, Natural Sciences and Information Technologies, University of Primorska, Glagoljaška Ulica 8, 6000 Koper, Slovenia.
- Institute of Environmental Protection and Sensors, Beloruska Ulica 7, 2000 Maribor, Slovenia.
ORCID-Profile: Zala Štukovnik
Förderung
- The Slovenian Research and Innovation Agency
- Slovenian Research and Innovation Agency
- Republic of Slovenia
- Ministry of Higher Education, Science and Innovation
- European Union
Zitieren
APA
Štukovnik, Z., Perko, N., & Bren, U. (2026). Rapid Eukaryotic Impedimetric Biosensing of Naproxen and Isoniazid: A Proof-of-Concept for Acute Toxicity Monitoring. Biosensors, 16(5), 298. https://doi.org/10.3390/bios16050298
Vancouver
Štukovnik Z, Perko N, Bren U. Rapid Eukaryotic Impedimetric Biosensing of Naproxen and Isoniazid: A Proof-of-Concept for Acute Toxicity Monitoring. Biosensors. 2026;16(5):298. doi:10.3390/bios16050298
BibTeX
@article{tukovnik2026,
author = {Štukovnik, Zala and Perko, Nik and Bren, Urban},
title = {Rapid Eukaryotic Impedimetric Biosensing of Naproxen and Isoniazid: A Proof-of-Concept for Acute Toxicity Monitoring},
journal = {Biosensors},
year = {2026},
volume = {16},
number = {5},
pages = {298},
doi = {10.3390/bios16050298}
}
EUVIMED